---
title: "Globus Medical, Inc. (GMED.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GMED.US.md"
symbol: "GMED.US"
name: "Globus Medical, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T08:59:48.613Z"
locales:
  - [en](https://longbridge.com/en/quote/GMED.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GMED.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GMED.US.md)
---

# Globus Medical, Inc. (GMED.US)

## Company Overview

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.globusmedical.com](https://www.globusmedical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: B (0.22)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 14 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 23.49% |  |
| Net Profit YoY | 216.18% |  |
| P/B Ratio | 2.29 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 10850067956.18 |  |
| Revenue | 3100664000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 13.30% | B |
| Profit Margin | 18.92% | A |
| Gross Margin | 69.20% | A |
| Revenue YoY | 23.49% | A |
| Net Profit YoY | 216.18% | A |
| Total Assets YoY | 15.46% | B |
| Net Assets YoY | 15.76% | B |
| Cash Flow Margin | 132.69% | B |
| OCF YoY | 23.49% | A |
| Turnover | 0.61 | B |
| Gearing Ratio | 13.00% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Globus Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "23.49%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "216.18%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.29",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "10850067956.18",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3100664000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "13.30%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "18.92%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "69.20%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "23.49%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "216.18%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "15.46%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "15.76%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "132.69%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "23.49%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.61",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "13.00%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 18.49 | 12/183 | 38.67 | 26.47 | 22.21 |
| PB | 2.29 | 63/183 | 2.71 | 2.29 | 1.89 |
| PS (TTM) | 3.50 | 79/183 | 4.28 | 3.50 | 3.09 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **14**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 6 | 43% |
| Overweight | 4 | 29% |
| Hold | 4 | 29% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 79.93 |
| Highest Target | 123.00 |
| Lowest Target | 90.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/GMED.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/GMED.US/norm.md)
- [Related News](https://longbridge.com/en/quote/GMED.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/GMED.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**